Aspen Pharmacare (OTCMKTS:APNHY) Trading 6% Higher – Here’s Why

Aspen Pharmacare (OTCMKTS:APNHYGet Free Report)’s stock price rose 6% during trading on Thursday . The company traded as high as $8.09 and last traded at $8.09. Approximately 585 shares were traded during mid-day trading, a decline of 43% from the average daily volume of 1,033 shares. The stock had previously closed at $7.63.

Aspen Pharmacare Stock Up 0.7%

The business’s fifty day simple moving average is $7.76 and its 200 day simple moving average is $6.56.

About Aspen Pharmacare

(Get Free Report)

Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.

Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.

Read More

Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.